Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides
- 1 January 1995
- journal article
- Published by Springer Nature in Virus Genes
- Vol. 9 (2) , 113-119
- https://doi.org/10.1007/bf01702654
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Inhibition of Human Immunodeficiency Virus Type 1-mediated Cytopathic Effects by Poly(L-lysine)-conjugated Synthetic Antisense OligodeoxyribonucleotidesJournal of General Virology, 2008
- Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotidesFEBS Letters, 1993
- New approaches in cancer pharmacology: Drug design and developmentEuropean Journal Of Cancer, 1992
- A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interactionCell, 1990
- Novel features of retroviruses associated with human diseasesFEBS Letters, 1990
- Inhibition of Antigen-Induced Lymphocyte Proliferation by Tat Protein from HIV-1Science, 1989
- Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′‐terminus and their interaction with DNA within mammalian cellsFEBS Letters, 1989
- The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic miceNature, 1988
- D‐Penicillamine inhibits transactivation of human immunodeficiency virus type‐1 (HIV‐1) LTR by transactivator proteinFEBS Letters, 1988
- Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)Science, 1985